Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Contrast Agents Regain ‘Drug’ Status, But Ophthalmic Products Still Subject To Genus Decision
Jan 04 2023
•
By
Brenda Sandburg
Certain products to be regulated as drugs rather than as devices under omnibus year-end legislation. • Source: Shutterstock
More from Legal & IP
More from Pink Sheet